01/26/2017 - 12:07pm

CRN partnered with BrandHive, a Utah-based marketing agency with  more than 20 years experience in the dietary supplement industry, to develop the media buy for the advertising campaign.

01/26/2017 - 11:03am

"At this time, we are actively engaged in discussion with Rite Aid regarding how to proceed," Walgreens Boots Alliance CEO Stefano Pessina told shareholders. "These discussions include taking into account anything that is required to gain approval."

01/24/2017 - 2:59pm

The proposed $37 billion merger between Aetna and Humana hits a roadblock with a ruling from a federal judge in a lawsuit between the companies and the federal government. 

01/24/2017 - 2:27pm

The bill reached impressive levels of bipartisan support in the prior Congress, with half of the Senate and two-thirds of the U.S. House of Representatives co-sponsoring the measure.

01/20/2017 - 3:21pm

Newly elected President Donald Trump lists six top issues, but health care is not one of them.

01/19/2017 - 3:11pm

"There are already a number of laws ... that help to fight the meth problem in Michigan," CHPA stated, "including the NLPE which serve as strong barriers to meth makers [obtaining] PSE."

01/19/2017 - 12:02pm

The percentage of Americans who approve of Obamacare reached its highest level of 48%, but nearly an equal number disapprove.

01/18/2017 - 10:01am

Bayer AG has joined a host of companies, including General Motors, Hyundai and Walmart,  that have pledged to either keep or create jobs in the U.S., The Wall Street Journal reported Wednesday. The Journal cited Trump transition team spokesman Sean Spicer, who said Bayer’s decision was the result of “the president-elect’s focus on creating a better business climate here in the United States.” Bayer is currently seeking regulatory approval for its planned $57 billion purchase of seed maker Monsanto, and committed research investments and "several thousand" new high-tech positions in the U.S. once that deal is successfully completed. (The Wall Street Journal)


01/17/2017 - 5:56pm

For the fourth consecutive year, NCPA asked its members to rank legislative priorities. For the 115th Congress, the top three concerns are DIR fees, generic pricing transparency and any willing provider provision.